Skip to main content
logo
Jack Nathan Medical Corp. (JNHMF)
OTCMKTS · Delayed Price · Currency is USD
0.0036
-0.0001 (-2.70%)
At close: Jun 2, 2025

Chimerix Revenue

In the fiscal year ending January 31, 2025, Jack Nathan Medical had annual revenue of 8.71M CAD with 26.41% growth.

Revenue
8.71M CAD
Revenue Growth
+26.41%
P/S Ratio
0.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
636.32K USD

Revenue Chart

* This company reports financials in CAD.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Jan 31, 20258.71M1.82M26.41%
Jan 31, 20246.89M-8.60M-55.53%
Jan 31, 202315.49M5.85M60.68%
Jan 31, 20229.64M5.79M150.21%
Jan 31, 20213.85M234.98K6.50%
Jan 31, 2020 Pro Pro Pro
Jan 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Endo, Inc.1.73B
Veradigm588.02M
Tian'an Technology Group1.78M
Elite Pharmaceuticals84.04M
Glass House Brands215.62M
Northwest Biotherapeutics1.47M
American Oncology Network1.76B
Silence Therapeutics27.70M
Revenue Rankings

Jack Nathan Medical News

More News